Chuck Grassley actually said...

The current drug price system is so opaque that it is easy to see why there are many questions about PBM motives and practices.

This bill puts sunshine on PBMs and saves taxpayers $740 million.

Prohibits deceptive, unfair pricing schemes, including spread pricing and arbitrary clawbacks of payments made to pharmacies.

The Prescription Pricing for the People bill requires the FTC to study pharmaceutical intermediaries, including vertical integration.